Strategic Tie-ups, Exchange Listings, and New Indexes Introduced - Analyst Notes on Grace, Cytec, BioFuel, Pacific Ethanol and Chemtura

NEW YORK, July 21, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding W.R. Grace & Co. (NYSE: GRA), Cytec Industries Inc. (NYSE: CYT), BioFuel Energy Corp. (NASDAQ: BIOF), Pacific Ethanol, Inc. (NASDAQ: PEIX) and Chemtura Corporation (NYSE: CHMT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4936-100free.

--
W.R. Grace & Co. Analyst Notes
On July 16, 2014, W.R. Grace & Co.'s (Grace) stock increased 1.53% to end the day at $98.24, compared to the previous day's closing price at $96.79. The Company's stock went up 4.90% during the past three trading days, compared to the Dow Jones Industrial Average which rose 1.14% and to S&P 500 which grew 0.72% during the same trading period. The full analyst notes on Grace are available to download free of charge at:

http://www.analystsreview.com/Jul-21-2014/GRA/report.pdf

--
Cytec Industries Inc. Analyst Notes
On July 8, 2014, Cytec Industries Inc. (Cytec) announced that it has formed a strategic collaboration with Dralon GmbH to support the research and development of large tow industrial grade carbon fiber. The Company anticipates the demand for tow carbon fiber to increase in the coming years. This growth is said to be driven by the increased use in industrial markets such as automotive which aims to achieve lighter-weight vehicles with greater fuel efficiency. Shane Fleming, Chairman, President and CEO of Cytec, commented, "Cytec offers a strong channel to market given our position today of supplying high performance automotive applications, as well as our decades of experience supplying carbon fiber composite technology to the aerospace industry. We are actively pursuing the development of carbon fiber based composites for the next addressable serial automotive market." The full analyst notes on Cytec are available to download free of charge at:

http://www.analystsreview.com/Jul-21-2014/CYT/report.pdf

--
BioFuel Energy Corp. Analyst Notes
On July 2, 2014, BioFuel Energy Corp. (BioFuel) announced that it has received a written notification from the Nasdaq Stock Market LLC (Nasdaq), which establishes that the Nasdaq Listing Qualifications Panel has granted BioFuel's request for continued listing on the Nasdaq Capital Market provided that provided that (1) on or before November 4, 2014, the Company closes the previously announced acquisition of the equity interests of JBGL Builder Finance LLC and certain subsidiaries of JBGL Capital, LP, from certain affiliates of Greenlight Capital, Inc. and James R. Brickman and (2) the resulting combined company satisfies all requirements for initial listing on The Nasdaq Capital Market upon consummation of the transaction. According to the Company, it is diligently working to complete the acquisition and the related transactions, including the preparation of a Nasdaq listing application for the combined company. The full analyst notes on BioFuel are available to download free of charge at:

http://www.analystsreview.com/Jul-21-2014/BIOF/report.pdf

--
Pacific Ethanol, Inc. Analyst Notes
On July 1, 2014, Pacific Ethanol, Inc. (Pacific Ethanol) announced that it has been successfully included in the Russell 3000®, Russell 2000® and Russell Global Indexes as a result of the annual Russell Investments reconstitution of its comprehensive set of U.S. and global equity indexes which was finalized on June 27, 2014. The full analyst notes on Pacific Ethanol are available to download free of charge at:

http://www.analystsreview.com/Jul-21-2014/PEIX/report.pdf

--
Chemtura Corporation Analyst Notes
On July 16, 2014, Chemtura Corp's (Chemtura) stock increased 1.03% to end the day at $25.58, compared to the previous day's closing price at $25.31. The Company's stock increased 1.47% during the past three trading months, compared to the Dow Jones Industrial Average which rose 4.34% and to S&P 500 which rose 6.40% during the same trading period. The full analyst notes on Chemtura are available to download free of charge at:

http://www.analystsreview.com/Jul-21-2014/CHMT/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review